GlaxoSmithKline promotes David Mawdsley to top global media relations role

Pharmaceutical giant GlaxoSmithKline has promoted David Mawdsley to the role of vice president of global media relations.

Changes to the team: GSK
Changes to the team: GSK
He replaces Phil Thomson, who took on the senior vice president for global communications role in June.

In his new role, Mawdsley will oversee the company’s engagement with the media globally.

He has been promoted from his role as vice president, investor relations and has been a member of the IR team since 2006. He joined GSK in 2003 and, prior to investor relations, was director and deputy head of the UK corporate media relations team.

Prior to joining GSK, Mawdsley worked in corporate comms for National Grid and held several senior advisory roles in the UK Conservative Party. He started his career in comms at the public affairs consultancy TCG, advising clients such as McDonald's and Motorola.

GSK has also promoted Sally Ferguson to take over from Mawdsely as vice president and head of global investor relations. She has been a member of the IR team since 2006.

Ferguson joined GSK in 2001 as a member of the business and commercial analysis team within global product strategy.

Prior to joining GSK, Sally was a market analyst at Novartis UK and a consultant at Datamonitor Healthcare, a specialist research company.

Both Mawdsley and Ferguson will report to Thomson.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in